Atlas
Back to Pharma Services
Fund · Service·Pharma Services

Abcam

Cambridge, UKabcam.com1expert edge

Cambridge-based provider of validated antibodies, reagents, biomarkers, and assays for life sciences research; acquired by Danaher for $5.7B in December 2023 to expand drug discovery capabilities.

Why interesting to a deal team

Expert advised on $5.7B sale to Danaher; demonstrates M&A expertise in life sciences tools and reagent suppliers serving pharma R&D.

Experts connected to this company

ES

Eric Stewart

Senior Managing Director, European M&A

Leerink Partners

Fund GPLondon

Stewart built Leerink's European healthcare M&A practice from scratch, bringing a decade of Lazard deal relationships spanning Mallinckrodt, Abcam/Danaher and Galderma.

Sources